Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cristina Raimondi
EGFR Inhibitor as Second-Line Therapy in a Patient With Mutant RAS Metastatic Colorectal Cancer: Circulating Tumor DNA to Personalize Treatment
JCO Precision Oncology
Cancer Research
Oncology
The Rationale for Liquid Biopsy in Colorectal Cancer: A Focus on Circulating Tumor Cells
Expert Review of Molecular Diagnostics
Forensic Medicine
Genetics
Pathology
Molecular Medicine
Molecular Biology
Related publications
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-Egfr Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
JAMA Oncology
Cancer Research
Oncology
Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer
Scientific Reports
Multidisciplinary
Change in Circulating Tumor DNA After Hepatic Resection for Metastatic Colorectal Cancer
HPB
Hepatology
Gastroenterology
Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation
OncoTargets and Therapy
Oncology
Pharmacology
Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
Clinical Colorectal Cancer
Oncology
Gastroenterology
HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Frontiers in Genetics
Genetics
Molecular Medicine
Xeloda as First-Line Therapy of Metastatic Colorectal Cancer-Our Experience
Archive of Oncology
Oncology
Hematology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
